PATENT CLAIM ANALYSIS

Application Number: 16034046
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["530", "327000"]

Abstract:
The invention provides non-hormonal vitamin D conjugated via the third carbon on the vitamin D backbone to parathyroid hormone (PTH) proteins that result in increased absorption, bioavailability or circulating half-life when compared to non-conjugated forms.

Claim (Index 1):
A carrier-drug conjugate, comprising a targeting group that is a non-hormonal vitamin D conjugated at the carbon 3 position to a protein having parathyroid hormone (PTH) activity.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 95.0
- Lexical Diversity: 1.11429
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14919601', '14919572', '14919671', '14401519', '14542581']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7493677020578535
- 35 USC 102 Novelty (BERT): 0.6450649548481334
- Combined Prediction Score: 0.7389374273368815
- Mean Citation Score: 472.212292
- Max Citation Score: 637.79346
- Similarity Product: 588.2528626048064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test